Compare Bio Protocol (BIO) vs Chainlink (LINK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs Chainlink — how do they compare? Bio Protocol trades at Rp443.11 (market cap Rp1T, Rp177,9M 24h volume), while Chainlink trades at Rp157,048 (market cap Rp117,38T, Rp3,82T 24h volume). The key difference: Chainlink is far larger — about 117.4× Bio Protocol's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 748,1M / 1B LINK (75%) for Chainlink. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 17 Days and Chainlink for 62 Days on average.
| BIO | LINK | |
|---|---|---|
Market Cap | Rp1T | Rp117,38T |
Volume (24h) | Rp177,9M | Rp3,82T |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 748,1M / 1B LINK (75%) |
Typical Hold Time | 17 Days | 62 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp424.33 with a market cap of Rp965.85M, showing neutral technical signals amid bearish moving averages. The token's circulating supply of 2.3M out of 3.3M max indicates 69% circulation with an average hold time of 17 days. Recent technical indicators show mixed signals with RSI in neutral territory while ADX suggests some buying momentum. Support and resistance levels are well-defined between Rp398 and Rp500.
Overall outlook remains neutral with key opportunities in protocol adoption growth, though risks include limited liquidity and typical crypto volatility. Investors should monitor network activity closely as the token operates in a competitive blockchain ecosystem without major recent protocol updates.
Chainlink is currently trading at Rp157,048 with a market cap of Rp117.38 trillion, showing bullish momentum with strong moving average signals. The token trades near resistance at Rp157,143 after recent positive developments including a former Chainlink executive joining the SEC's crypto task force. With 75% of the 1 million LINK supply in circulation and an average hold time of 62 days, the network maintains steady tokenomics while technical indicators show mixed signals with RSI suggesting potential overbought conditions.
Overall outlook remains cautiously optimistic with key opportunities in Chainlink's oracle network expansion and regulatory developments. Major risks include technical overbought conditions and crypto market volatility. Investors should monitor support at Rp152,863 and resistance at Rp157,143 for near-term direction.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About Chainlink
Founded in 2017 by Sergey Nazarov , Chainlink is a blockchain abstraction layer that enables universally connected smart contracts. Through a decentralized oracle network, Chainlink allows blockchains to securely interact with external data feeds, events and payment methods, providing the critical off-chain information needed by complex smart contracts to become the dominant form of digital agreement.
Read more on LINK →
